120 related articles for article (PubMed ID: 20139130)
1. An integrative genomic approach in oesophageal cells identifies TRB3 as a bile acid responsive gene, downregulated in Barrett's oesophagus, which regulates NF-kappaB activation and cytokine levels.
Duggan SP; Behan FM; Kirca M; Smith S; Reynolds JV; Long A; Kelleher D
Carcinogenesis; 2010 May; 31(5):936-45. PubMed ID: 20139130
[TBL] [Abstract][Full Text] [Related]
2. The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro.
Jenkins GJ; Harries K; Doak SH; Wilmes A; Griffiths AP; Baxter JN; Parry JM
Carcinogenesis; 2004 Mar; 25(3):317-23. PubMed ID: 14656946
[TBL] [Abstract][Full Text] [Related]
3. The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS.
Jenkins GJ; Cronin J; Alhamdani A; Rawat N; D'Souza F; Thomas T; Eltahir Z; Griffiths AP; Baxter JN
Mutagenesis; 2008 Sep; 23(5):399-405. PubMed ID: 18515815
[TBL] [Abstract][Full Text] [Related]
4. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma.
Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H
Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457
[TBL] [Abstract][Full Text] [Related]
5. Deoxycholic acid promotes development of gastroesophageal reflux disease and Barrett's oesophagus by modulating integrin-αv trafficking.
Prichard DO; Byrne AM; Murphy JO; Reynolds JV; O'Sullivan J; Feighery R; Doyle B; Eldin OS; Finn SP; Maguire A; Duff D; Kelleher DP; Long A
J Cell Mol Med; 2017 Dec; 21(12):3612-3625. PubMed ID: 28941013
[TBL] [Abstract][Full Text] [Related]
6. Inducible nitric oxide synthase (iNOS) and nitric oxide (NO) are important mediators of reflux-induced cell signalling in esophageal cells.
McAdam E; Haboubi HN; Forrester G; Eltahir Z; Spencer-Harty S; Davies C; Griffiths AP; Baxter JN; Jenkins GJ
Carcinogenesis; 2012 Nov; 33(11):2035-43. PubMed ID: 22826608
[TBL] [Abstract][Full Text] [Related]
7. Deoxycholic acid induces proinflammatory cytokine production by model oesophageal cells via lipid rafts.
Quilty F; Freeley M; Gargan S; Gilmer J; Long A
J Steroid Biochem Mol Biol; 2021 Nov; 214():105987. PubMed ID: 34438042
[TBL] [Abstract][Full Text] [Related]
8. Deoxycholic acid impairs glycosylation and fucosylation processes in esophageal epithelial cells.
Byrne AM; Sharma R; Duggan G; Kelleher D; Long A
Glycobiology; 2012 May; 22(5):638-48. PubMed ID: 22223758
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action.
Tselepis C; Perry I; Dawson C; Hardy R; Darnton SJ; McConkey C; Stuart RC; Wright N; Harrison R; Jankowski JA
Oncogene; 2002 Sep; 21(39):6071-81. PubMed ID: 12203119
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells.
Mühlbauer M; Allard B; Bosserhoff AK; Kiessling S; Herfarth H; Rogler G; Schölmerich J; Jobin C; Hellerbrand C
Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G1000-8. PubMed ID: 14726307
[TBL] [Abstract][Full Text] [Related]
11. Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: The potential role of anti-oxidants in Barrett's oesophagus.
Jenkins GJ; D'Souza FR; Suzen SH; Eltahir ZS; James SA; Parry JM; Griffiths PA; Baxter JN
Carcinogenesis; 2007 Jan; 28(1):136-42. PubMed ID: 16905748
[TBL] [Abstract][Full Text] [Related]
12. Bile acids are multifunctional modulators of the Barrett's carcinogenesis.
Burnat G; Majka J; Konturek PC
J Physiol Pharmacol; 2010 Apr; 61(2):185-92. PubMed ID: 20436219
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
14. Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development.
Kazumori H; Ishihara S; Kinoshita Y
Gut; 2009 May; 58(5):620-8. PubMed ID: 19136512
[TBL] [Abstract][Full Text] [Related]
15. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.
Huo X; Juergens S; Zhang X; Rezaei D; Yu C; Strauch ED; Wang JY; Cheng E; Meyer F; Wang DH; Zhang Q; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G278-86. PubMed ID: 21636532
[TBL] [Abstract][Full Text] [Related]
16. In vitro and ex vivo models of extended reflux exposure demonstrate that weakly acidic mixed reflux heightens NF-kB-mediated gene expression.
Cronin J; Alhamdani A; Griffiths AP; Baxter JN; Brown T; Jenkins GJ
Dis Esophagus; 2011 Jul; 24(5):360-70. PubMed ID: 21143697
[TBL] [Abstract][Full Text] [Related]
17. Curcumin abrogates bile-induced NF-κB activity and DNA damage in vitro and suppresses NF-κB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett's oesophagus.
Rawat N; Alhamdani A; McAdam E; Cronin J; Eltahir Z; Lewis P; Griffiths P; Baxter JN; Jenkins GJ
Clin Transl Oncol; 2012 Apr; 14(4):302-11. PubMed ID: 22484638
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression.
Doak SH; Jenkins GJ; Parry EM; Griffiths AP; Baxter JN; Parry JM
Mutat Res; 2004 Mar; 547(1-2):133-44. PubMed ID: 15013707
[TBL] [Abstract][Full Text] [Related]
19. In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids.
Peng S; Huo X; Rezaei D; Zhang Q; Zhang X; Yu C; Asanuma K; Cheng E; Pham TH; Wang DH; Chen M; Souza RF; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G129-39. PubMed ID: 24852569
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of nuclear factor-kappaB activity and interleukin-8 abundance in oesophageal adenocarcinoma; a useful strategy for monitoring these biomarkers.
Jenkins GJ; Mikhail J; Alhamdani A; Brown TH; Caplin S; Manson JM; Bowden R; Toffazal N; Griffiths AP; Parry JM; Baxter JN
J Clin Pathol; 2007 Nov; 60(11):1232-7. PubMed ID: 17220207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
